This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Bisphosphonate use ‘raises cancer risk by 13%’

Bisphosphonate use is associated with an increased risk of cancer, with the effect particularly strong in women rather than men, according to new research on a UK cohort.

Researchers from London found a 13% increased risk for upper gastrointestinal cancer in those who had taken bisphosphonates compared with patients who had not.

The study included 8,636 men and women who had a recorded incident of upper gastrointestinal cancer, matched to 34,544 controls with no record of upper gastrointestinal cancer. Bisphosphonate use was defined as any patient ever prescribed one during the 13-year study period.

Women taking bisphosphonates had a 34% increased risk of cancer, adjusted for smoking status, compared with controls, whereas men experienced a 19% decrease in risk.

When they restricted analysis to look at oesophageal cancer alone, they found a 43% increase in risk for women who had taken bisphosphonates, compared with controls. For men there was a 13% decrease compared with controls.

The researchers concluded: ‘In the presence of an association and with a plausible mechanism to account for possible causation, it would be sensible to exercise caution in prescribing bisphosphonates to patients with pre-existing risk factors for upper gastrointestinal cancer.’

PLOS One 2012, online 24 October

Readers' comments (1)

  • Pulse is getting more and more like the Daily Mail. Headline for this article: Bisphosphonate use ‘raises cancer risk by 13%’ - dated 19 Nov 2012. Headline for article in side bar: Biophosphonates 'not a cancer risk' - dated 8 Oct 2012. Please, people!

    Unsuitable or offensive? Report this comment

Have your say